Variant report
Variant | nsv975928 |
---|---|
Chromosome Location | chr11:56279445-56280681 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5M6P | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184176970 | chr11:56279830-56279831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537869001 | chr11:56279839-56279840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556813349 | chr11:56279864-56279865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575188943 | chr11:56279874-56279875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552793524 | chr11:56279877-56279878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78047980 | chr11:56279907-56279908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201352530 | chr11:56279918-56279919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557575480 | chr11:56279925-56279926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573005909 | chr11:56279960-56279961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539919300 | chr11:56279966-56279967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558237251 | chr11:56279970-56279971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572200108 | chr11:56279978-56279979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139309615 | chr11:56279989-56279990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544260159 | chr11:56280039-56280040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563166962 | chr11:56280060-56280061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533717854 | chr11:56280085-56280086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs56394926 | chr11:56280110-56280111 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs144076763 | chr11:56280134-56280135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188628745 | chr11:56280157-56280158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549179920 | chr11:56280167-56280168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191954643 | chr11:56280197-56280198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537831978 | chr11:56280235-56280236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377087041 | chr11:56280250-56280251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568806615 | chr11:56280263-56280264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539311182 | chr11:56280284-56280285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145997892 | chr11:56280285-56280286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182896035 | chr11:56280321-56280322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139998100 | chr11:56280378-56280379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555155802 | chr11:56280410-56280411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73469369 | chr11:56280411-56280412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544224542 | chr11:56280444-56280445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556149375 | chr11:56280445-56280446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs577722082 | chr11:56280459-56280460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75460118 | chr11:56280478-56280479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560861200 | chr11:56280479-56280480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527859270 | chr11:56280492-56280493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543237947 | chr11:56280493-56280494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561214436 | chr11:56280520-56280521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531734937 | chr11:56280534-56280535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576523192 | chr11:56280537-56280538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs594568 | chr11:56280589-56280590 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs557645883 | chr11:56280594-56280595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113276829 | chr11:56280599-56280600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs151256452 | chr11:56280618-56280619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566794183 | chr11:56280629-56280630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs680490 | chr11:56280634-56280635 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs543241012 | chr11:56280653-56280654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555585141 | chr11:56280659-56280660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560022309 | chr11:56280666-56280667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56279800-56281400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |